GOLDMAN SACHS GROUP INC - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 109 filers reported holding TREACE MED CONCEPTS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$1,600,088
-46.4%
122,051
+4.6%
0.00%
-100.0%
Q2 2023$2,986,158
-4.2%
116,738
-5.6%
0.00%0.0%
Q1 2023$3,116,029
+409.8%
123,701
+365.3%
0.00%
Q4 2022$611,212
-14.0%
26,586
-17.5%
0.00%
Q3 2022$711,000
+259.1%
32,228
+133.8%
0.00%
Q2 2022$198,000
-83.0%
13,784
-77.7%
0.00%
Q1 2022$1,168,000
+220.9%
61,739
+429.9%
0.00%
Q2 2021$364,00011,6510.00%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q4 2022
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 1,595,387$36,677,9474.40%
EMERALD MUTUAL FUND ADVISERS TRUST 945,973$21,747,9191.35%
EMERALD ADVISERS, LLC 1,188,246$27,317,7761.32%
Perceptive Advisors 1,946,403$44,747,8051.26%
Novo Holdings A/S 637,317$14,651,9180.92%
SECTORAL ASSET MANAGEMENT INC 179,924$4,136,4530.80%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 493,213$11,338,9670.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 139,960$3,2180.50%
TimesSquare Capital Management, LLC 976,000$22,4380.32%
DRIEHAUS CAPITAL MANAGEMENT LLC 770,817$17,721,0830.26%
View complete list of TREACE MED CONCEPTS INC shareholders